Radiopharm Theranostics (RADX)

• Market cap: $33.5M
• 1 day: -1.85%
• 5 days: -5.76%
• 1 month: -14.66%
• 3 months: -22.73%
• 6 months: -26.09%
• Year to date: -17.64%
• 1 year: -23.01%
• 5 years: -75.95%
• 10 years: -75.95%
• Sector: Healthcare
• Industry: Biotechnology

About: Radiopharm Theranostics Ltd is an Australian-based clinical-stage radiotherapeutics company targeting cancer. The company has a pipeline of approximately four licensed platform technologies, with diagnostic and therapeutic applications at both the pre-clinical and clinical stages of development. The company is engaged in research, development, and commercialization of health technologies.

Employees: 14